-
Brazilian health regulator Anvisa said testing of Russia's Sputnik-V COVID-19 vaccine has not begun in Brazil, as reported in the Financial Post.
-
A spokeswoman for the agency said Brazil's Paraná and Bahia states, which have testing and production or distribution agreements for Sputnik-V, have not yet filed requests for clinical trials in the country.
-
"There have been numerous meetings, physical and online, with no documents on the Russian vaccine materializing yet," she remarked.
-
The Russian Direct Investment Fund (RDIF), which is marketing Sputnik-V, did not immediately reply to a request for comment.
-
Meanwhile, trials for the vaccine developed by AstraZeneca and Oxford University, and another potential vaccine by China's Sinovac Biotech are being conducted at a dozen sites and initial data sent in to Anvisa.
-
"This is still not a formal request for registration of these vaccines. We will only consider that when all the documents have been filed," the spokeswoman noted.
To read more NewsPoints articles, click here.
